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Abstract
The Herpesviridae are a family of viruses widely spread in nature that can infect 
a wide variety of species. After the primary infection, the human alphaherpesviri-
nae sub-family remains quiescent in the nerve ganglia from which it can periodi-
cally reactivate, causing clinical manifestations. Although spontaneous recurrences 
are possible, a wide variety of internal and external triggers may lead to transfor-
mation of the Herpes Simplex and Varicella-Zoster Viruses from a dormant to a 
proliferative state. Sunlight is a potent stimulus for the alphaherpesvirinae reactiva-
tion. The purpose of this paper is to analyze various features of this correlation and 
several steps you can take to lower your risk of triggering a herpes outbreak after 
sun exposure. Learning how to reduce the recurrence is extremely important and 
it is necessary: to perform a gradual and progressive sun exposure; to know what 
garments to wear; to know the environmental conditions of exposure; to know each 
skin phototype; to use a protective product against UVB and UVA with sun protec-
tion factor suitable for each phototype and environmental conditions.
Keywords: sunlight, UV, UVR, herpes virus, HSV, herpes zoster, VZV, sunscreens, 
prevention
1. Introduction
The sunlight and specifically the Ultraviolet component of its radiation (UVR) is 
among the major causes of alphaherpesviridae (αHV) reactivation. Various aspects 
of this correlation will be analyzed in this chapter, as well as how it interferes with 
the virus-host relationship and what kind of precautions should be taken to reduce 
the risks of painful relapse.
2. Herpes virus
The Herpes Virus (HV) are a members of the family Herpesviridae widely 
spread in nature that can infect a wide variety of species of at least two animal 
phyla, the Chordata and the Mollusca [1]. It is a virus about 150–200 nm in diam-
eter, with icosahedral nucleocapsid DNA double helix containing an envelope which 
derives from the nuclear membrane of the host cell with viral glycoproteins that 
protrude on the surface.
To date a total of 8 human HVs are known, having the characteristic of establishing 
a life-long latent infection: a state from which the virus can be reactivated and result in 
recurring disease. The HV family is divided into three subfamilies (Alphaherpesvirinae, 
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Betaherpesvirinae, and Gammaherpesvirinae); among these, only the αHV creates skin 
lesions in humans [2]. The Herpes Simplex Virus (HSV), creating the general clinical 
picture of herpetic disease, and the Varicella-Zoster Virus (VZV), which is the cause of 
chickenpox and Herpes Zoster (HZ), both belong to αHV.
2.1 Clinical aspects of αHV lesions
The transmission of αHV occurs by close contact with a person who actively elim-
inates the virus. The viral diffusion occurs from lesions; however, it can occur even 
if they are not visible. After the primary infection, the αHV remains quiescent in the 
nerve ganglia from which it can periodically reactivate, causing clinical manifesta-
tions. The HSV commonly cause a relapsing mucocutaneous infection affecting the 
skin, mouth, lips, eyes and genitals. Serious common variants include encephalitis, 
meningitis, neonatal herpes, and infections disseminated in immunosuppressed 
patients. There are two types of HSV: Herpes Simplex Virus 1 (HSV-1) and Herpes 
Simplex Virus 2 (HSV-2) and both types can cause oral or genital infections. In most 
cases, the HSV-1 causes gingivostomatitis, cold sores, herpetic keratitis, and lesions 
in the upper body. The HSV-2 generally causes lesions to the genitals and to the skin 
of the lower half of the body. Approximately 70% of population in USA is seroposi-
tive for HSV [3] but only the 20%, due to a decline in cellular immunity, presents 
the recurrent form that can occur with a variable frequency. The mucocutaneous 
manifestations occur in two forms: primary infection and recurrent infection. Both 
forms appear on the skin with an erythematous lesion with vesicles (the size of a pin’s 
head) clustered that can merge to form a bubble and then break, leaving an erosion 
and then a crust that falls after a few days. The primary infection may be unappar-
ent, so that most individuals carry antibodies but have no memory of the initial 
Herpes. In the forms where the disease manifests itself usually appears in children 
aged between 6 months and 3 years of age. It presents a clinical presentation often 
more serious than the classical that is shown in the recurrent form. In fact, it is asso-
ciated with general malaise with temperature over 39°C, pain, dysphagia, sialorrhea, 
fetid breath. Despite the impressive appearance it resolves on its own in 10–15 days. 
During the primary infection the transmission of the virus is favored by alterations 
of the epithelial lining, so that it penetrates and multiplies in the epithelial cells, with 
lysis of the infected cells due to the formation of a large number of virions. The virus 
then disappears from the coating epithelium and goes, passing through the sensory 
nevi, to localize in the nerve ganglia corresponding to the entry area. In recurrent 
manifestations usually, after a prodromal period (typically <6 h in HSV-1 relapses) 
characterized by burning or pruritus, small vesicle bunches appear stretched on an 
erythematous base. The bunches are 0.5–1.5 cm in size but can flow together. Skin 
lesions of the nose, ears, eyes, fingers or genitals can be particularly painful. The 
vesicles normally persist for a few days, then break and dry, forming a thin yellowish 
crust. The lesions can be associated with a burning sensation, tingling or itching with 
or without fever and small adenopathies, the evolution lasts 1–2 weeks. The herpetic 
lesions typically heal completely, but recurrent lesions in the same site can cause 
atrophy and scarring. Skin lesions can develop bacterial superinfections. In patients 
with depression of cell-mediated immunity due to Human Immunodeficiency Virus 
infection (HIV) or other causes, long-lasting or progressive lesions may persist for 
weeks or longer. Herpes labialis (HL) occurs on the edge of the vermilion of the 
lip or, less frequently, on the mucosa of the hard palate. HL is the most common 
clinical form in the facial region [4]. In the United Kingdom it accounts for 1% of 
medical consultations [5]. The acute gingivostomatitis is characteristic of child-
hood. Instead, herpetic pharyngitides can occur in adults and children; occasionally, 
mediated by oro-genital contacts, caused by the HSV-2. The intraoral and gingival 
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vesicles normally break in a time ranging from a few hours to 1–2 days, leaving an 
ulcer. Fever and pain often occur; after the resolution, the virus remains quiescent 
in the semilunar ganglion. The Genital Herpes (HG) is the most widespread sexu-
ally transmitted ulcerative disease in developed countries. HG can be caused by 
HSV-1 or HSV-2. Ocular HSV lesions (HO) can cause corneal scarring, and recurrent 
ocular HSV infections are a leading cause of vision loss [6]. VZV belongs to the αHV 
subfamily and produces two clinical syndromes: varicella (chickenpox) and zoster 
(shingles). Both “zoster” (from Greek) and “shingles” (from French and Latin 
languages) correspond to the English word “belt,” which describes the characteristic 
narrow, bandlike rash from the spine to the front of the torso on one side of the body 
[7]. VZV is transmitted by inhalation of respiratory secretions or contact with skin 
lesions. During the primary infection (varicella), the virus becomes latent in the 
dorsal ganglia and zoster is due to reactivation from latency, a process which occurs 
most frequently in elderly [8]. Each person with a history of varicella has approxi-
mately a 30% lifetime risk of at least one VZV reactivation [9].
2.2 Pathogenesis
HSV infections are most commonly acquired through direct contact with muco-
sal tissue or secretions of another infected person and the majority of infections are 
established within the stratified squamous epithelium of the skin and oral or genital 
mucosa [10]. The virus is able to cause a lytic infection with direct death of epithe-
lial cells. Following infection, the virus enters sensory nerves that innervate the skin 
or mucosa and travels via retrograde axonal transport to the neuronal cell body: 
here it can establish a life-long latent infection in dorsal root ganglia [11]. In the 
cell body there is the nucleus, where the virus makes use of the cell’s apparatus for 
DNA replication and transcription. The axonal cytoskeleton and molecular motors, 
like kinesins, are involved in the active transport of viral capsids and glycoproteins: 
their transport seems to be fast, bidirectional and microtubules dependent [12–14]. 
The mechanisms that regulate entry into lytic replication versus latent infection in 
neurons remain largely undefined. The mechanism of HSV entry is mediated by 
direct interaction between viral envelope glycoproteins and cell surface receptors 
that mediate attachment, initiate signaling cascades, or trigger virus internalization.
The entry process involves multiple steps:
1. Attachment to the cell surface: the virus initially uses filopodial interaction to 
migrate toward the cell body and to initiate the access. This process is termed 
‘viral surfing’ [15]. In this process, the initial binding of virus to cells is medi-
ated through association of viral glycoprotein (g)B and/or gC with heparan 
sulfate proteoglycans (HSPG)s located on the cell surface, facilitating the sub-
sequent binding to coreceptors. The gC makes the first contact with HSPGs on 
the cell surface, but in the absence of gC, gB can take over this function [16].
2. Binding to cell receptors and coreceptors: the major virus attachment is glyco-
protein gD and the most studied coreceptor are nectin-1, herpes virus entry 
mediator or 3-O-sulfated HS. The interaction of the viral glycoproteins with 
these cell receptors induces conformational changes recruiting gB, gH, and gL 
for fusion of the viral envelope with the cell plasma membrane leading to viral 
penetration and capsid release in the cytoplasm [17]. The link between gD and 
its receptor can activate the gH/gL complex.
3. Fusion with cellular membrane: gH/gL provides the signal required for 
activation of gB. Binding of gB to one of its receptors, is required for 
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delivery of the viral nucleocapsid to the cytoplasm accomplished either by 
membrane fusion or endocytosis/phagocytosis-like uptake. Beside mem-
brane fusion, mechanisms of endocytosis and/or a phagocytosis-like uptake 
have been proposed. The endocytosis of HSV particles is atypical, because 
not mediated by clathrin-coated pits or caveolae. The phagocytosis process 
requires a cytoskeletal rearrangement with activation of Rho GTPases [18].
After fusion between the cellular membrane with the infecting virus, a viral 
transactivator tegument protein (VP16), is released into the cytoplasm. The viral 
capsid is then transported to the nuclear membrane along the microtubule network 
and, through nuclear pore, the viral DNA is released into the nucleus. VP16 forms a 
transactivation complex binding in the cytoplasm host cell factor-1 (HCF-1) (pro-
tein that contains a nuclear localization sequence), and in the nucleus the homeodo-
main protein Octamer binding protein-1 (Oct-1). These proteins form a trimeric 
complex able to activate the immediate early (IE) gene expression [19]. Successful 
lytic replication is dependent on the expression of the viral IE genes within all 
infected cells. While this model of VP16 activation of IE gene expression is well 
understood, the mechanisms implicated in neuronal latency are debated and consid-
erable gaps remain in our knowledge of how different signaling pathways act on the 
latent genome for reactivation. Following the establishment of latent infection, viral 
lytic gene expression is silenced, and the lytic gene promoters are associated with 
repressive heterochromatin [20]. Key experiments performed in the 1980s indicated 
that latent genomes in the brain stems of infected mice have a nucleosomal structure 
[21]. Later studies confirmed that the latent viral genome associates with cellular 
histones in the trigeminal ganglia of mice [22, 23]. Coinciding with the silencing of 
lytic transcripts, the viral lytic gene promoters become enriched with characteristic 
heterochromatic histone modifications [24, 25]. While it appears that factors intrin-
sic to neurons play a key role in the transcriptional silencing of the virus, viral gene 
products expressed during latent infection can also modulate the chromatin struc-
ture [23, 26, 27]. This modulation likely promotes long-term latency, while priming 
the genome for reactivation following the appropriate stimuli [28, 29].
3. Trigger
Although spontaneous recurrences are possible, a wide variety of internal 
and external triggers may lead to transformation of the HSV from a dormant to a 
proliferative state [30].
Some of the following factors may trigger herpes symptoms:
• Sunlight: some study demonstrates UVR as a powerful trigger for HL and it also 
seems that HZ can be stimulated by sun exposure [8, 31].
• Exposure to heat or cold [5, 32].
• Local tissue trauma may make herpes symptoms appear such as: undergoing 
a surgery [33], laser surgery [34], dental procedures [35], and Tattoos [36]. 
Another unusual form of traumatic triggering of HSV reactivation may be neu-
rosurgery: after a delay of approximately 1 week, destructive encephalitis may 
develop with fever and seizures, and with typical viral inclusion bodies demon-
strated by histopathology [37].
• Persistent mental stress and fatigue [33, 38]. Psychological stress can also dysreg-
ulate cellular immunity, and enhance latent αHV reactivation [39]. Importantly, 
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chronically stressed low socioeconomic status individuals have higher antibody 
titers to latent HV. Additionally, dementia caregivers have greater HSV-1 anti-
body titers compared with demographically matched controls [40, 41].
• Physical stress: fever[5], illness (infection, septicaemia).
• Nerve damage: minimal stimulation or inapparent trauma to the trigeminal sen-
sory root is sufficient to activate latent HSV in humans [42].
• Radiotherapy: the example of radiation therapy against a brain tumor initiating 
HSV encephalitis suggests that other trigger factors also should be studied [43].
• Immunosuppression: when the immune system is dysregulated, by HIV or 
chemotherapy or corticosteroid administration, people generally exhibit 
greater disease susceptibility and latent HSV or VZV reactivation [43, 44]. 
Maladaptive alterations in cellular immune function can enhance herpesvirus 
reactivation and replication, resulting in elevated herpesvirus antibody titers. 
For instance, organ transplant patients have elevated herpesvirus antibody 
titers [39, 45–47].
• Sexual intercourse: some people find that the friction of sexual intercourse irri-
tates the skin and brings on symptoms of HG. Even if the friction of intercourse 
seems to be a trigger for symptoms, it won’t probably cause a flare-up every 
time [5].
• Hormonal changes, like those that occur in the menstrual cycle, can affect her-
pes outbreaks. There is a significant association of development of recurrence 
HSV and the luteal phase of the menstrual cycle [5].
• Change in antiviral activity of the saliva [5].
Whether a common pathway exists for pathogenetic processes induced by these 
disparate reactivating factors remains to be determined.
4. The Sun radiation and interaction whit skin
The skin is continually subjected to the action of external agents including solar 
radiation. One of the scientifically documented triggers for herpes outbreaks is the 
ultraviolet (UV) light found in direct sunlight.
4.1 The Sun as origin of the electromagnetic energy
The Sun is a G-type main-sequence star and is the largest and the most massive 
object in the solar system. The Sun is the source of the overwhelming majority 
of light, heat, and energy on Earth’s surface, and is powered by nuclear fusion of 
hydrogen nuclei into helium. As a result of these nuclear reactions a continuous 
flow of particles and electromagnetic waves called the solar wind is released in the 
cosmos. Solar wind is a constant stream of plasma and particles emanating from the 
sun and is the extension of solar corona into interplanetary space. The solar wind 
invests all the planets, can reach speeds above 700 km/s and have a density that 
varies from 10 to 100 particles/cm3. Sunlight consists mostly of short wavelength 
ionizing radiation (cosmic, gamma, and X-rays) and long wavelength non-ionizing 
radiation (UV, visible, and infrared) [48].
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UVR is the area of the electromagnetic spectrum that is considered biologically 
the most active and therefore of greatest impact on health and disease [49]. For 
convenience, we separate UV somewhat arbitrarily into UVA (315–400 nm), UVB 
(280–315 nm) and UVC (100–280 nm). UVC together with ionizing radiation 
is largely absorbed by the upper atmosphere and does not reach us on the earth’s 
surface. Most UVR that reaches the earth’s surface is UVA (95%), only a small 
percentage is UVB (approximately 5%). UVR peaks around noon and is increased 
by reflection from snow, water, and sand [50]. UVA, but not UVB, can penetrate 
glass [51]. The solar radiation is omnipresent during daylight hours. At ground level 
the amount of UV mainly comprises UVA, and a small percentage (<10%, variable 
by time of day, season and altitude) of UVB. The doses of UV absorbed vary greatly 
within a person and between people, depending on the position, time of day, 
season, type of clothing, habits and skin pigmentation.
The non-ionizing radiation are not lethal to living organisms but can cause 
damage to the skin and eyes if taken chronically and/or in large quantities. Animals 
defend themselves from the action of these waves thanks to the presence on their skin 
of hairs, feathers and scales. Humans, having lost the hair during evolution, have to 
use melanin as a means of protection. The peculiarity of the UV is that they are one 
of the few environmental factors that can cause both disease and protection against 
the disease [52]. The sun exposure is pleasant for us because it causes the following 
positive effects: we are pervaded by a pleasant feeling of warmth and well-being 
linked to Infrared Radiation (IR) and Visible Light (VL), we release chemical factors 
that act as antidepressants (VL), appears after a few hours a dark and transient tan-
ning (UVA), followed by a golden and lasting tan (UVB) after 24–48 h. Other posi-
tive actions are the production of “antirachitic” vitamin D (UVB) and a regulation of 
hormonal functions (VL). Unsuitable exposure can lead to immediate or delayed side 
effects. The most frequent damages caused by sunlight are: sunburn, photoallergic 
reactions, photo-aging, skin tumors, eye diseases and immunosuppression.
4.2 UVR and immune skin suppression
Exposure to UVR has a profound effect on the skin immune system. It has both, 
pro-inflammatory as well as immunosuppressive effects and it involves both innate 
and adaptive immunity. Examples of pro-inflammatory responses clinically observed 
include sunburn, photodermatosis [53]. Examples of the immunosuppressive effect is 
the use of UV for psoriasis or lichen planus treatment. Both UVB and UVA wavebands 
contribute to sunlight-induced immunosuppression, although an interaction between 
them makes sunlight more suppressive than each waveband alone. It is therefore 
important to protect the skin from both UVB and UVA. Exposure to doses of UVR 
that are only 30–50% as high as what is required to cause barely detectable sunburn, 
suppressing immunity in humans. Therefore, normal daily outdoor activities during 
spring and summer months are likely to cause some degree of immunosuppression 
in a large proportion of humans [54]. It is both obvious and striking that UVR at 
rather low doses suppresses an immune response. Thus, one may speculate that a 
certain degree of immunosuppression may be beneficial. The skin is an organ which 
is constantly exposed to potential allergens; in addition, the skin is an organ which 
is prone to autoimmunity [55, 56]. Hence, it is tempting to speculate that a certain 
degree of constant immunosuppression by daily solar exposure may prevent the 
induction of these immune responses. Owing to the multiple different experimental 
systems suppressed by UV and the dependence on dose, timing, waveband and skin 
site, we currently do not have a comprehensive understanding of how UV has this 
potent effect on the immune system. However, many different molecular and cellular 
events have been described. The cells involved in immunosuppressive activity are 
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keratinocytes, lymphocytes, Langerhans cells (LC), macrophages and mast cells. UVR 
induced immune suppression is known be mediated through T cells [57]. The relation 
of immune suppression is linked to various subtypes of regulatory immune cells such 
as regulatory T cells (Tregs) and regulatory B cells (Bregs) depends on UVR doses and 
type of immune response [58–61]. Furthermore, UVR has also profound effects on 
antigen-presenting cells. It damages LCs, so that they migrate from epidermis into the 
draining lymph nodes [62, 63]. It affects mast cells which are known to be involved 
in immune suppression [64]. It releases cytokines leading suppressor macrophages 
to infiltrate the skin and activating B lymphocytes in draining lymph nodes so that 
they have suppressor function. It is likely that interaction between these UV-altered 
antigen-presenting cells result in the activation of suppressor T lymphocytes. There 
is good evidence that these T suppressor cells are mainly responsible for reduction in 
immunity caused by UV [54]. The molecular mechanisms responsible for disruption of 
cellular immunity and some of the key events observed in the skin after the UVR expo-
sure are described below (Figure 1). The cellular-molecular phenomena occur in suc-
cessive steps. In the first step, which concerns keratinocytes, LC, urocanic acid (UCA) 
and corneum lipids, some ray-sensitive photoreceptors absorb photons, with different 
susceptibility for the different wavelengths (so the results can be different depending 
on the type of UV) and initiate a molecular cascade that damages and modifies the 
cellular biochemistry. The molecular mechanisms responsible for disruption of cellular 
immunity begins with DNA damage, trans to cis isomerization of UCA, and peroxida-
tion of lipids. In the second step, the cells damaged by UVR produce mediators (espe-
cially cytokines) that modify the activity of LC. In fact, both for the cytokines and for 
their own damaged DNA, in addition to the alteration of the antigen presentation, they 
migrate into the lymph nodes. The cytokines produced in this phase are numerous. It 
has also been observed that UVR suppresses HSV antigen presentation in epidermal 
cells and leads to the reduction of type 1 cytokine release, an important key-factor in 
immunological control for viruses such as HSV [65, 66]. Photoproducts of DNA such 
as pyrimidine dimers or 6-4-photoproducts result in the production and release of 
various immunosuppressive factors such as Tumor Necrosis Factor (TNF)-alpha and 
Figure 1. 
The molecular mechanisms responsible for disruption of cellular immunity and some of the key events observed 
in the skin after the ultraviolet radiation exposure.
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interleukin (IL)-10 by keratinocytes and other cells in the skin. The UVB waveband 
in particular also directly leads to isomerization of trans-UCA to cis-UCA. Cis-UCA 
induces immune suppression by binding to the 5-HT2A receptor, leading in turn 
to production of IL-10 by T-cells and B-cells. It may also indirectly lead to mast cell 
degranulation and stimulate the release of Platelet-Activating Factor (PAF). Formation 
of reactive oxygen species (ROS) by UVR not only induces and contributes to DNA 
damage but also directly stimulates PAF synthesis or the production of PAF-like 
molecules. UVR can also directly upregulate specific antimicrobial peptides (AMP) 
such as human beta-defensin-2, beta-defensin-3, S100A7, and RNase7 which are 
expressed by keratinocytes, lymphocytes, monocytes, and mast cells. These AMPs not 
only serve as initiators of innate immune response but they also communicate with the 
adaptive immune system and can activate it. The third step, as a result of the impact 
of UVR on the skin, is the appearance of an immunosuppressive microenvironment 
with abundance of TNF, IL-4 and IL-10 linked to Langerhans cell (LC) migration 
into lymph nodes and neutrophil and macrophage recruitment to the skin. As overall 
result, there is a modulation on T lymphocytes characterized by a global suppression of 
them and by a switch in the balance between two lymphocytes classes: the suppression 
of the Th1 population (implicated in immunity to intracellular organisms like viruses, 
through IL-2 and INF); an increase of Th2 (implicated in immunity against extracel-
lular microbes such as bacteria, through IL-4/10) and an induction of Tregs and Bregs 
leading ultimately to functional immune suppression [67, 68].
4.3 Is UVR a cause of αHV recurrence?
A systematic epidemiological review was carried out in 2008 identifying 9 
diseases that show sufficient evidence of a causal relationship with UVR exposure. 
These include the reactivation of the HSV. The other diseases are: melanoma, squa-
mous cell carcinoma of the skin, basal cell carcinoma, solar keratoses, sunburns, 
cataracts, pterygium, squamous cell carcinoma of the cornea and conjunctiva [52]. 
In medical scientific literature several works have been published demonstrating 
the recurrence of αHV after exposition to solar UVR (sUVR) or experimental UVR 
(eUVR) both on human [69–74] and on animal models; [75, 76] due to these reasons 
most dermatology manuals recommend using sunscreen to avoid HSV recurrence 
[77]. Several papers have shown a correlation between UV exposure and occurrence 
of HSV-1 [74, 78]. Approximately the 25–50% of HL are attributed, at least in part, to 
sUVR exposure. In one scientific article it was shown that the use of sunscreen alone 
versus placebo showed 95–100% suppression of HL recurrences in 2 crossover trials 
after application of 4 Minimal Erythema Doses (MED) of eUVR [70, 79]. To evaluate 
the role of exposure to sUVR in primary and recurrent HSV-1 infections, the self-
reported cause of infection among diagnosed patients in Hyogo Prefecture, Japan, 
was investigated. Among 4295 infected patients, 3678 had HSV-1, and 2656 of those 
patients (72.2%) had a recurrent flare-up. Sun-induced HSV-1 flare-up was reported 
by 10.4% of the total study population. However, this increased to 19.7% among 
patients diagnosed in July and August, to 28% among patients younger than 30 years 
diagnosed in July and August, and to 40% among patients younger than 30 years 
diagnosed in July and August with a recurrent infection [32]. Although these studies 
did not analyze HG, data from another study show that HG recurrences also occur 
more easily after exposure to UV rays. For example, one study found that patients 
with HG—in this case, on the buttocks—were likely to experience recurrences 
shortly after being exposed to eURV. Another study on HO compared the reactivation 
with sUVR, detecting an increase in reactivation in more exposed subjects, actu-
ally even if data are unclear due to confounding factors that can be superimposed, 
such as in particular the stress that might act both directly determining reactivation 
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and indirectly probably creating a greater need to expose to the sun [80]. As far as 
the VZV is concerned, one work reported a higher incidence of total HZ cases and 
cases of zoster in males during summer (from July to September) with a significant 
increase in May–June in patients studied in 1992–1998 in Ferrara in north-east Italy 
[81]. Another work shows the incidence of HZ peak for all subjects and for males it 
coincides with the maximum UVR months in summer. This association was not found 
for women, considered alone. It has not been explained why this difference should 
occur between men and women, but one possible explanation could be that older 
men tend to have more activities outside than women, such as gardening or walking, 
and therefore more exposure to sUVR. In addition to the increase in the incidence of 
zoster in summer, there was a significant increase over the same period in cases where 
lesions occurred on the face were compared to body sites normally covered [8]. In 
addition to considering the possible influence of the seasons on the incidence of αHV 
mucocutaneous lesions, some studies have succeeded in demonstrating a correlation 
with the UVR dose, geographical location, age and the body location. A dose of eUVR 
capable of triggering the recurrence of HL, is 4 MED, which corresponds to 80 min 
of sun exposure around 12 in July, at sea level taken by an individual with unpro-
tected fair skin [70]. In some works, a slight latitudinal gradient of HL and a peak of 
prevalence in adulthood are demonstrated [82–84]. Another work highlighted the 
photolocalization of viral exanthema by observing a particular distribution of skin 
lesions, especially for VZV and HSV, between exposed areas and areas covered by 
clothes, preferring a location exposed to rays [85]. The recurrence time of HL after 
eVR exposure may be immediate (within 48 h) or delayed (after 2–7 days); [78] the 
time required for virus reactivation at the latency site [86], virus transport to the skin 
surface (it is estimated that the speed, demonstrated in vitro, is 3–5 mm/h)] and the 
virus replication in the epithelium with production of typical lesions (>24 h) [87, 
88]. The eUVR had a beneficial effect on the virulence of HSV in an animal model. In 
fact, in a study it has been shown that 80% of mice irradiated before infection, and 
then re-irradiated several weeks later, developed recrudescent lesions. Only 20% of 
equivalent mice had not been irradiated before infection, but when irradiated after 
infection developed recrudescences [85].
4.4 How does solar radiation stimulate viral reactivation?
The exposure to sunlight has been associated with HSV reactivation [89–91]. It 
has been observed that 30% of causes of reactivation and axon migration to the skin 
are due to sudden exposure to sunlight and this seems also linked to the triggering 
of various mechanisms. There are many ways in which UV exposure is thought to 
impact αHV, and HSV recurrence in particular, directly through 3 pathways and 
probably also indirectly with unknown methods [85]. The first pathway is the 
depression of immune response due to UV exposure. The second pathway by which 
UVR may affect recurrence is directly through HSV reactivation [80, 85]. The third 
pathway study molecular events that trigger reactivation. The first pathway is based 
on the hypothesis that the virus continually tends to migrate from the ganglion 
to the skin. According to this theory, the normal immune response is activated 
through cell-mediated mechanisms of lymphocytes and macrophages and through 
the release of cytokines. In this way most of the migrations of ganglion-to-skin 
viruses is suppressed, as they are represented by few viral units and because the 
system is already sensitized, preventing a clinically evident reactivation because the 
infection remains sub-clinical. In the first pathway, the exposure to UVR deter-
mines the imbalance and suppression of the immune system, in a dose-dependent 
manner, which triggers a series of events so that local control of the reactivation is 
lost causing some virions to escape from immune control and the disease becomes 
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manifest. It does not seem that through this mechanism we can identify a “remote” 
influence that reactivates the virus, but only a local effect of more peripheral virions 
approaching the skin. In the second pathway, UVR directly determine an imbal-
ance or radiation damage to epidermal and dermal cells, which are stimulated to 
repair producing transcription factors that in addition to activating cellular gene 
expression also activate the viral one and also inhibit the stimulus to apoptosis [80]. 
Especially the cell repair, through the c-Jun and c-Fos transcription factors, acti-
vates the HSV transcription promoter (infected cell polypeptide 0), leading to HSV 
transcription and reactivation [92]. Additionally, these repair pathways circumvent 
the activity of HSV latency-associated transcript preventing infected neurons from 
undergoing apoptosis and in turn, reactivating HSV [93]. Despite these models, 
significant gaps remain in our understanding of how these stimuli correlate with 
reactivation of the virus resulting in clinical disease. The third pathway is a molecu-
lar model that explains how UVR at the body surface results in multiple neuronal 
effects or hormonal alteration that could be relevant to reactivation. For example, a 
damage to innervated tissues that results in loss of the neurotrophin-producing cells 
and changes in the levels of regulatory neuropeptides, neurotrophins, neurotrans-
mitters may occur following UV irradiation [94]. Nerve growth factor (NGF) 
deprivation was first found to trigger HSV reactivation in primary neuronal models 
of HSV latency using rat sympathetic neurons [95]. In vivo injection of anti-NGF 
serum into latently infected rabbits has also been shown to enhance reactivation of 
HSV [96]. Furthermore, interruption of signals downstream of the NGF receptor 
triggered reactivation in a variety of in vitro models of HSV latency [97–100], and 
has been shown to enhance explant mediated reactivation ex vivo [101, 102]. In 
addition, UV treatment in mice results in increased serum levels of cortisol and may 
act through a pathway that is similar to psychological stress-induced reactivation. 
It was also noted that the dexamethasone, a synthetic corticosteroid, stimulates 
reactivation of HSV-1 both ex vivo and in primary neuronal cultures, and the 
closely related bovine HSV-1 can also be reactivated in latently infected calves by 
intravenous injection of dexamethasone [98, 101, 103].
4.5 Do sun-screen reduce HSV recurrence?
To date four studies have been published on sunscreen used by volunteers who 
suffered from HL, two studies in which subjects were exposed to eUVR and two 
to sUVR. Two randomized controlled trials with a crossover design demonstrated, 
using a solar simulator, the effectiveness of lip sunscreen in reducing HL after UV 
exposure. The first study was conducted on 38 patients: it showed that after expo-
sure to artificial ultraviolet, equal to 4 MED, HL developed in 27 patients (71%) 
treated with placebo. In contrast, when a sun protection factor (SPF) 15 sunscreen 
was applied during UV exposure, no lesion developed on 35 patients [70]. The sec-
ond work carried out on 19 individuals, exposed to 4 MED for 10 min of ultraviolet 
light under artificial conditions, found that sunscreen significantly reduces relapses 
compared to placebo: one on 19 patients (5%) with sun protection against 11 out of 
19 individuals (58%) with placebo [79].
Studies carried out in the natural environment have given different results.
The first work has been carried out in natural conditions in three ski resorts: 
Park City, Utah (January 21–28) SnowMass, Colorado (February 25 to March 3) and 
Keystone, Colorado (April 8–15) at a latitude between 40 and 39°. Fifty-one volun-
teer skiers were analyzed, showing that a SPF 15 sun screen compared to placebo was 
not effective to prevent reactivation of the virus. HL developed in 3 out of 24 subjects 
using protection and in 3 out of 27 with placebo [104]. This work was criticized by 
stating that the UV dose received by volunteer skiers during the trial was 1–3 MED 
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per day, which is lower than the 4 MED needed to trigger recurrence [70]. Probably 
due to this limitation, this study is not mentioned in the main guidelines for HL 
treatment [105]. Furthermore, it is not reported what amount of sunscreen was 
applied by skiers. However, in the latter two experiments carried out with artificial 
light the sunscreens were likely applied in a dose sufficient to respect the SPF value 
[106]. The second randomized, crossover study was carried out in northern Sardinia 
(Italy) on 20 volunteers who went to beach at a latitude of 40–41° using a sunblock 
stick with SPF 30. The study was conducted between May and July 2017 around the 
summer solstice (June 21st) when the sun reaches its highest point in the sky, to make 
the total amount of solar irradiance equal in the two sequential study periods. For 
each volunteer the study period lasted 60 days: 30 with protection and 30 without 
protection. The month with or without product application was randomly assigned 
to each patient so as 10 subjects started the trial without protection and 10 with 
protection and the opposite during the following month. During the month when 
volunteers had to use a protection, they were requested to apply the sunblock stick on 
the vermilion and lip skin two times consecutively creating a double protective layer 
before going out or going to the sea. The protection was repeated every 2 h, after 
eating or drinking, smoking and after a swim. 4 MED were reached and exceeded 
by volunteers several times during the 2 months of study. In fact, each volunteer 
remained at the beach at around 12 am with an average of 4.5 ± 0.95 h in the period 
with stick and 4.3 ± 0.94 h in the period without stick exceeding the aforementioned 
dose. Results demonstrated that sunscreen is effective in protecting the upper lip 
from reactivating the HL. In fact, only one volunteer out of 20 had a HL during the 
period of sunscreen use versus 10 out of 20 without sunscreen during the studied 
period. One volunteer from the second group reported two sequential HL. The single 
event during the period with labial photoprotection was unleashed in the last week, 
the 11 events of the period without photoprotection appeared from the second week 
of exposure. All lesions were clinically diagnosed with the help of Tzanck’s cytodiag-
nostic examination [107]. In summary, these three studies, even though with a small 
number of subjects, showed that sunscreens can reduce the relapses caused by HSV 
following UVR exposure both in the laboratory and in the open air.
5. Treatment
If you suffer from relapsing HSV or you want to reduce the risk of the onset of 
HZ especially in summer, the most effective way is to avoid sunlight. Obviously, this 
is not always possible for most people. Even if someone deliberately avoids going 
to the beach, the face and other exposed parts of the body will still come in contact 
with direct sunlight throughout the day. What should be done to avoid solar radia-
tion or minimize its effects?
5.1 Practical photoprotection strategy
To minimize the risk of a HS recurrence it is necessary: to perform a gradual 
and progressive sun exposure; to know what garments to wear; to know the 
environmental conditions of exposure; to know each skin phototype; to use a 
protective product against UVB and UVA with SPF suitable for each phototype 
and environmental conditions. Sun exposure must be gradual and progressive. 
The ideal would be a tanning obtained with irradiation times that do not induce 
erythema for long periods, in order to activate mechanisms of natural photoprotec-
tion. In fact, it has been shown that sub-erythematous doses of UVB produce a 
tan. It is advised wearing long trousers and long-sleeved shirts during summer to 
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avoid exposing more skin than necessary to direct sunlight and also a hat to protect 
the face from direct sunlight and to prevent lips and face from coming into direct 
contact with UVR. However, a garment does not offer a complete UV barrier. If it is 
wet, it has less dry effect in stopping UV. Dark colors absorb more UVR, while clear 
colors are more effective against IR. Cotton has a low protective factor compared 
to silk and blue jeans. We must therefore choose thick and darker fabrics to have 
an effective protection such as blue jeans. The effects of solar radiation also vary 
according to environmental conditions. For example, the amount of UVR in the 
environment varies during the day (maximum value between 12 and 16), in the 
different months of the year (period with more irradiation June–July–August in 
the northern hemisphere), in relation to the altitude (the quantity increases by 6% 
every km of height) and at the latitude (greater quantity in the tropics). When the 
sky is uniformly covered there is a reduction of about 50% of the UVR compared 
to the clear sky, but if it is partially cloudy the irradiation is not uniform and may 
decrease or increase depending on the shape and properties of the clouds. In the 
environment, in addition to direct rays, also the reflected ones might be taken: the 
reflection is 80% on the snow (almost 100% if the snow is fresh and compact), 20% 
in the water, 17% on the sand and 3% on the grass. In addition, the water works as a 
lens and we must remember that if you are immersed up to 40–50 cm 5% of the rays 
affects us by reflection even on those parts of the skin (area under the chin, inside 
the arms, under the buttocks) which usually are not exposed. In addition, artificial 
UV exposure such as tanning beds and other devices that produce UVR should be 
avoided. The phototype indicates the ability to defend against the UVR that varies 
from individual to individual. It can be easily obtained taking into account the color 
of the complexion, the eyes and the hair and also the reaction of the skin to the sun 
exposure. The lower skin types (blond, red hair with fair skin that hardly tans) are 
those who do not adapt to sun exposure and are subjected to skin damage. It is also 
important to protect daily the skin and the HV recurrence zones with a sunscreen.
5.2 Sunscreens
Sunscreen is a lotion, spray, gel or other topical product that absorbs or reflects 
some of the sun’s UVR and thus helps protect against sunlight.
Depending on the mode of action, sunscreens can be classified into physical 
sunscreens (i.e. those that reflect the sunlight) or chemical sunscreens (i.e. those 
that absorb the UVR). Chemical, organic sunscreens absorb over relatively narrow 
wavebands, mainly in the UVB but nowadays also extending into the UVA. Physical 
sunscreens are inorganic substances that reflect and scatter both UV and visible 
radiations [107]. Use of sunscreen can reduce chronic damaging and the carcino-
genic effects of UV radiation and recurrence of cutaneous HV.
Currently, it is recommended to spread the sunscreen on the skin in two layers 
in such a way that its thickness is as close as possible to 2 mg/cm2, which is what 
enables to achieve the expected SPF. In practice, however, only between 0.5 and 
1.5 mg/cm2 are used mostly because of the high price of sunscreen. The effect of 
application thickness is shown diagrammatically in 34 for the ideal scenario of 
uniform application. This demonstrates how light absorption depends strongly 
on thickness. For example, a sunscreen labeled SPF 16 is reduced to an SPF of 2 
if the consumer applies 0.5 mg/cm2. Uniformity of application is another related 
crucial factor. The same amount of sunscreen non-uniformly applied implies that 
some areas receive little or no sunscreen. In general, sun lotions should always be 
applied in abundant quantities, in 2 layers and repeated during the day, immedi-
ately after swimming and every 2 h if sweating occurs. Only after a few days it will 
it be possible to reduce the SPF of the cream used, once the skin has had the time 
13
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Sunlight and Herpes Virus
DOI: http://dx.doi.org/10.5772/intechopen.82643
to activate its defense systems. Use of sunscreen should never be interrupted, even 
once tanned, because the melanin filters 70% of the UVB but not the UVA and 
because over time its filtered capacity becomes less effective. The SPF is important 
in the choice of a solar product and the one suitable for each phototype should be 
increased if environmental conditions require it. The SPF is the ratio of the dose 
of UV radiation causing minimal erythema in unprotected skin to the dose which 
causes a minimal erythema in skin protected by the sunscreen. For example, if the 
normal MED is 30 mJ/cm2 and the MED of the protected skin is 450 mJ/cm2, the 
SPF is 15. In other words, application of sunscreen has caused an increase by a factor 
of 15 in the dose required to induce erythema. The SPF is principally a measure of 
the sunscreen UVB attenuation. Although conceptually very simple, it is often mis-
understood by the general public, who think that using a high factor sunscreen will 
protect the skin against the harmful effects of UV radiation. Even if the sunscreen 
provides the protection indicated by the SPF, a day’s exposure outdoors wearing 
a factor 15 sunscreen will still result in more than one MED for many individu-
als. This misconception often leads individuals to stay in the sun longer than they 
should. There is also a major difference between the highly controlled conditions in 
the sunscreen laboratory and outdoor real-life product use. [107]
6. Conclusion
Sunlight is the most common trigger in stimulating the HSV reactivation. It 
still not well known how the UVR determines the reactivation of the virus. Several 
hypotheses have been made but do not lead to a single common path with the other 
triggers. However, we know how to protect ourselves from solar radiation and what 
methods to use to avoid it or reduce its harmful effect on the skin.
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